Twelve patients were positive for IgM anti-B19, and the presence of B19V DNA was confirmed in two patients (0.46%).<h4>Conclusions</h4>Patients with hematological diseases, particularly thrombophilia, exhibit a high seroprevalence of B19V, indicating frequent prior exposure. This evidence concerns the gene CD40LG and hematologic disorder.